AMRI has acquired Excelsyn Ltd., a provider of chemical development and manufacturing services, located in North Wales, UK, for $19 million in cash. Excelsyn has 60 employees and had revenues of $15 million in 2009. The acquisition expands AMRI’s portfolio of development and large scale manufacturing facilities, as well as its customer base. Excelsyn provides development and large scale manufacturing services to large pharmaceutical, specialty pharmaceutical and biotechnology customers throug...